Cargando…
Anti-Phosphatidylserine, Anti-Prothrombin, and Anti-Annexin V Autoantibodies in Antiphospholipid Syndrome: A Real-Life Study
The antiphospholipid antibodies (aPL) increase the risk of developing thrombotic events and may coexist with a variety of autoimmune diseases. They can be detected chronically or temporarily in patients with infectious diseases, during drug therapy, or in cases of cancer. A thrombotic event with aPL...
Autores principales: | Roselli, Daniele, Bonifacio, Maria Addolorata, Barbuti, Giovanna, Rossiello, Maria Rosaria, Ranieri, Prudenza, Mariggiò, Maria Addolorata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416833/ https://www.ncbi.nlm.nih.gov/pubmed/37568869 http://dx.doi.org/10.3390/diagnostics13152507 |
Ejemplares similares
-
Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study
por: Sciascia, Savino, et al.
Publicado: (2019) -
Rational Laboratory Diagnostics of Antiphospholipid Antibodies: Anti-Cardiolipin, Anti-β2-Glycoprotein I, Anti-Prothrombin and Anti-Annexin V Antibodies
por: Borut, Bozic, et al.
Publicado: (2010) -
The introduction of anti-phosphatidylserine/prothrombin autoantibodies in the laboratory diagnostic process of anti-phospholipid antibody syndrome: 6 months of observation
por: Fabris, Martina, et al.
Publicado: (2014) -
Anti-Phosphatidylserine/Prothrombin Antibodies Are Associated with Adverse Pregnancy Outcomes
por: Žigon, Polona, et al.
Publicado: (2015) -
Anti-Phosphatidylserine-Prothrombin Antibodies are Associated with Outcome in a TIA Cohort
por: Mullen, Michael T., et al.
Publicado: (2012)